Skip to main content

Want a detailed portfolio tracker?

Eupraxia Pharmaceuticals (EPRX) P/E (2023 - 2026)

Eupraxia Pharmaceuticals (EPRX) P/E from Jan 3, 2023 to Jul 21, 2026. The TTM Eupraxia Pharmaceuticals (EPRX) P/E is -8.59. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Eupraxia Pharmaceuticals (EPRX)

YearP/EChange
2026-8.59-15.50%
2025-10.16+129.41%
2024-4.43-8.82%
2023-4.86N/A

Comparison Eupraxia Pharmaceuticals (EPRX) P/E with competitors

Eupraxia Pharmaceuticals (EPRX) P/E is -8.59.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.87%
FGENFibroGen Inc0.24-102.79%
CHRSCoherus Biosciences Inc0.85-109.88%
FBIOFortress Biotech Inc0.95-111.05%
ORMPOramed Pharmaceuticals Inc1.50-117.50%
AGENAgenus Inc3.01-135.04%
INVAInnoviva Inc3.15-136.72%
VXRTVaxart Inc3.55-141.33%
CRMDCorMedix Inc3.63-142.24%
CVACCureVac N.V.4.45-151.76%
GLPGGalapagos NV4.86-156.57%
SRPTSarepta Therapeutics Inc4.88-156.84%
ABEOAbeona Therapeutics Inc5.39-162.72%
ABUSArbutus Biopharma Corp5.60-165.14%
ZVRAZevra Therapeutics Inc5.89-168.54%
SPROSpero Therapeutics Inc6.23-172.51%
CGENCompugen Ltd6.31-173.51%
RIGLRigel Pharmaceuticals6.87-180.00%
SLXNSilexion Therapeutics Corp7.30-184.94%
OMEROmeros Corporation9.26-207.79%
AUPHAurinia Pharmaceuticals Inc9.58-211.59%
PLXProtalix BioTherapeutics Inc10.89-226.79%
ACADAcadia Pharmaceuticals Inc11.73-236.54%
TBPHTheravance Biopharma Inc12.26-242.76%
ADMAAdma Biologics Inc12.42-244.57%
HRMYHarmony Biosciences Holdings Inc13.82-260.90%
SABSSAB Biotherapeutics Inc14.14-264.57%
NAGENiagen Bioscience Inc14.82-272.51%
INCYIncyte Corp15.82-284.21%
REGNRegeneron Pharmaceuticals Inc15.86-284.60%
PBYIPuma Biotechnology Inc17.32-301.59%
CPRXCatalyst Pharmaceuticals Inc17.44-303.03%
EXELExelixis Inc17.54-304.18%
TGTXTG Therapeutics Inc18.97-320.80%
MDXGMimedx Group Inc20.55-339.27%
XOMAXOMA Royalty Corp22.87-366.32%
ARGXArgen X SE24.30-382.89%
CTMXCytomX Therapeutics Inc24.82-388.98%
XOMAOXOMA Royalty Corp25.34-395.07%
HALOHalozyme Therapeutics Inc25.62-398.32%
XOMAPXOMA Royalty Corp25.67-398.86%
VRTXVertex Pharmaceuticals Inc27.99-425.93%
RPRXRoyalty Pharma plc - Class A28.69-433.99%
SLNOSoleno Therapeutics Inc29.02-437.81%
ASNDAscendis Pharma A/S30.09-450.27%
LGNDLigand Pharmaceuticals Inc - Class B37.91-541.39%
APLSApellis Pharmaceuticals Inc39.02-554.30%
BMRNBiomarin Pharmaceutical Inc42.21-591.45%
KRYSKrystal Biotech Inc45.34-627.91%
ONCBeiGene Ltd69.54-909.62%
PHARPharming Group N.V.75.03-973.48%
TECHBio-Techne Corp101.96-1287.04%
VCELVericel Corp109.92-1379.75%
ALNYAlnylam Pharmaceuticals Inc117.96-1473.40%
GMABGenmab140.29-1733.32%
TLXTelix Pharmaceuticals Ltd162.15-1987.85%
CORTCorcept Therapeutics Inc212.86-2578.17%